R. Hewitt Pate - 27 Feb 2026 Form 4 Insider Report for CHEVRON CORP (CVX)

Role
Chief Legal Officer
Signature
/s/ Rose Z. Pierson, Attorney-in-Fact for R. Hewitt Pate
Issuer symbol
CVX
Transactions as of
27 Feb 2026
Net transactions value
-$6,981,869
Form type
4
Filing time
03 Mar 2026, 18:41:58 UTC
Previous filing
12 Feb 2026
Next filing
10 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pate R. Hewitt Chief Legal Officer 1400 SMITH STREET, HOUSTON /s/ Rose Z. Pierson, Attorney-in-Fact for R. Hewitt Pate 03 Mar 2026 0001469419

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVX Common Stock Options Exercise $4,159,089 +35,475 +415% $117.24 44,033 27 Feb 2026 Direct F1
transaction CVX Common Stock Sale $1,282,290 -6,958 -16% $184.29 37,075 27 Feb 2026 Direct F1, F2
transaction CVX Common Stock Sale $909,490 -4,900 -13% $185.61 32,175 27 Feb 2026 Direct F1, F3
transaction CVX Common Stock Sale $3,963,206 -21,237 -66% $186.62 10,938 27 Feb 2026 Direct F1, F4
transaction CVX Common Stock Sale $445,578 -2,380 -22% $187.22 8,558 27 Feb 2026 Direct F1, F5
transaction CVX Common Stock Options Exercise $6,401,460 +58,000 +678% $110.37 66,558 02 Mar 2026 Direct F1
transaction CVX Common Stock Sale $5,504,596 -29,260 -44% $188.13 37,298 02 Mar 2026 Direct F1, F6
transaction CVX Common Stock Sale $4,491,277 -23,757 -64% $189.05 13,541 02 Mar 2026 Direct F1, F7
transaction CVX Common Stock Sale $945,980 -4,983 -37% $189.84 8,558 02 Mar 2026 Direct F1, F8
holding CVX Common Stock 9,367 27 Feb 2026 By 401(k) plan
holding CVX Common Stock 20 27 Feb 2026 By Pate Family Trust
holding CVX Common Stock 13,264 27 Feb 2026 By Spouse Trust F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -35,475 -100% $0.000000 0 27 Feb 2026 Common Stock 35,475 $117.24 Direct F10
transaction CVX Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -58,000 -100% $0.000000 0 02 Mar 2026 Common Stock 58,000 $110.37 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 26, 2025.
F2 These shares were sold in multiple transactions at prices ranging from $183.90 to $184.85, inclusive. The price reported in Column 4 reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 8 to this Form 4.
F3 These shares were sold in multiple transactions at prices ranging from $185.05 to $186.04, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F4 These shares were sold in multiple transactions at prices ranging from $186.05 to $187.02, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F5 These shares were sold in multiple transactions at prices ranging from $187.06 to $187.46, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F6 These shares were sold in multiple transactions at prices ranging from $187.63 to $188.59, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F7 These shares were sold in multiple transactions at prices ranging from $188.64 to $189.62, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F8 These shares were sold in multiple transactions at prices ranging from $189.68 to $190.62, inclusive. The price reported in Column 4 reflects the weighted average sale price.
F9 The reporting person disclaims beneficial ownership of the shares held by his spouse's trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the shares held by his spouse's trust for purposes of Section 16 or for any other purpose.
F10 Option granted 1/25/2017. One-third of the shares subject to the option vested on January 31, 2018, January 31, 2019 and January 31, 2020, respectively.
F11 Option granted 1/29/2020. One-third of the shares subject to the option vested on January 31, 2021, January 31, 2022 and January 31, 2023, respectively.